The discussion of Düsseldorf today is exciting. My memory is screaming at me that in the SAB CC on Dec 7th that Jonah Sacha announced a recent, third cured HIV patient. Obviously, unrelated to Leronlimab but part of his prezie about long-term, en vivo LL mimicking the CCR5 deletion caused by delta32 mutation.

Well of course Sacha knows, but I think he mentioned same on Dec 7th.